首頁 > 市場調查報告書 > 食物/飲料

機能性食品益生菌

市場調查報告書

商品編碼

1512676

全球雙歧桿菌益生菌市場 - 2024-2031

Global Bifidobacterium Probiotic Market - 2024-2031

出版日期: 2024年07月10日 | 出版商:

DataM Intelligence | 英文 213 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球雙歧桿菌益生菌市場將於 2023 年達到 11 億美元，預計到 2031 年將達到 19 億美元，2024-2031 年預測期間複合年成長率為 8.8%。

消費者越來越意識到腸道健康的重要性以及包括雙歧桿菌在內的益生菌在維持腸道健康方面的作用。這種意識的提高正在推動不同人群對益生菌產品的需求，從而推動市場成長。製造商正在使其產品多樣化，以滿足不同消費者的喜好和需求，為消費者提供更多選擇，將益生菌融入日常生活中。

例如，2023 年 5 月 23 日，PanTheryx 的益生菌補充劑品牌 TruBiotics 推出了兩款專為解決女性健康各個方面問題而量身定做的新補充劑。這些膠囊的配方包含益生菌菌株的組合，這些益生菌菌株因其在促進消化和陰道健康方面的功效而聞名。這些菌株中包括動物雙歧桿菌，它被認為是研究最廣泛的消化健康有益細菌之一。

隨著消費者健康意識的增強，人們對包括雙歧桿菌益生菌在內的益生菌產品越來越感興趣，以支持亞太地區的消化健康和整體福祉。亞太地區的公司正在投資研發，探索益生菌的健康益處並開發創新產品。這包括研究雙歧桿菌益生菌在解決該地區普遍存在的特定健康狀況方面的功效。

動力學

提高消費者對腸道健康的認知

隨著越來越多的人認知到維持健康的腸道微生物群對整體健康的重要性，對益生菌補充劑和含有雙歧桿菌的食品的需求不斷成長。這種意識的提高促使消費者尋找能夠改善消化健康、增強免疫力和增強整體健康的產品，從而擴大了市場。

公司向消費者宣傳雙歧桿菌益生菌益處的行銷努力也發揮著至關重要的作用。透過強調對腸道健康的正面影響，這些活動吸引了更大的客戶群。因此，在知情且具有健康意識的消費者群體的推動下，全球雙歧桿菌益生菌市場正在經歷顯著成長。

例如，2023年10月10日，一家以生產跳跳糖為主食而聞名的廣東公司透過加入功能性成分來提高營養價值，從而創新了其產品線。該公司在競爭激烈的市場上推出了一系列注入維生素 C 和益生菌（特別是雙歧桿菌）的新糖果。

該公司傳統上以其跳跳糖產品而聞名，現在它正在利用其製造技術來創造一種富含促進健康成分的新穎糖果體驗。透過將維生素 C 和雙歧桿菌益生菌融入糖果配方中，該公司旨在為消費者提供一種方便、愉快的方式來增強免疫系統和支持消化健康。

對天然和有機產品的偏好日益成長

對天然和有機產品日益成長的偏好是推動全球雙歧桿菌益生菌市場的主要因素。隨著消費者擴大尋求更健康、更永續的選擇，他們開始轉向天然和有機益生菌來增強腸道健康。這種趨勢在注重健康的個人中尤其強烈，他們更喜歡不含合成添加劑和防腐劑的產品。

為了滿足這一需求，市場上的製造商正在專注於開發符合天然和有機標準的雙歧桿菌益生菌。這種轉變不僅吸引了更廣泛的客戶群，也鼓勵市場內的創新和產品多樣化。因此，對天然和有機產品的偏好極大地促進了全球雙歧桿菌益生菌市場的擴張和成長。

例如，2022年4月28日，中國乳製品巨頭伊利推出了最新的產品發布策略，重點介紹創新產品，以滿足不斷變化的消費者喜好。其中一項策略是推出富含益生菌和 GABA 作為主要成分的固體飲料。雖然伊利已在乳製品市場建立了強大的影響力，特別是在優格、起司和冰淇淋等益生菌產品方面，但這次進軍固體飲料的新業務標誌著其產品組合的戰略擴張。

嚴格的監管框架

嚴格的監管框架是全球雙歧桿菌益生菌市場的重大限制。不同地區的監管機構對益生菌產品的批准、標籤和行銷制定了嚴格的指導方針，以確保安全性和有效性。這些法規通常需要廣泛的臨床試驗和科學證據來證實健康聲明，這對製造商來說可能既昂貴又耗時。

因此，規模較小的公司面臨進入壁壘，甚至市場上的老牌企業也可能會遇到產品發布延遲和額外的合規成本。這種監管負擔可能會限制新雙歧桿菌益生菌產品的上市速度，也會減少消費者可獲得的產品種類。嚴格的監管框架是一個重大限制，影響著全球雙歧桿菌益生菌市場的成長和擴張。

例如，2023 年12 月27 日，監管機構最近收到了一份令人擔憂的不良事件報告，涉及一名早產兒，該嬰兒接受益生菌Evivo 和MCT 油（嬰兒健康）治療，作為預防壞死性小腸結腸炎的住院護理的一部分。不幸的是，在服用 Evivo 後，患者因 Evivo 中存在的長雙歧桿菌而出現敗血症，並隨後死亡。該事件是早產兒在接受作為疾病預防措施銷售的益生菌後出現不良事件的幾起報告案例之一。

There is increasing awareness among consumers about the importance of gut health and the role of probiotics, including bifidobacterium, in maintaining it. This heightened awareness is driving demand for probiotic products across various demographics, fueling market growth. Manufacturers are diversifying their product offerings to cater to different consumer preferences and needs, providing consumers with more options to incorporate probiotics into their daily routines.

For instance, on May 23, 2023, PanTheryx's probiotic supplements brand, TruBiotics, introduced two new supplements tailored to address various aspects of women's health. The formulation of these capsules includes a combination of probiotic strains known for their efficacy in promoting digestive and vaginal health. Among these strains is Bifidobacterium animalis, recognized as one of the most extensively researched beneficial bacteria for digestive well-being.

As consumers become more health-conscious, there is a growing interest in probiotic products, including bifidobacterium probiotics, to support digestive health and overall well-being in the Asia-Pacific. Companies in the Asia-Pacific region are investing in research and development to explore the health benefits of probiotics and develop innovative products. This includes studying the efficacy of bifidobacterium probiotics in addressing specific health conditions prevalent in the region.

Dynamics

Increasing Consumer Awareness About Gut Health

As more people recognize the importance of maintaining a healthy gut microbiome for overall well-being, there is a growing demand for probiotic supplements and foods that contain bifidobacterium. This heightened awareness is prompting consumers to seek out products that can improve digestive health, boost immunity, and enhance overall wellness, thus expanding the market.

Marketing efforts by companies to educate consumers about the benefits of bifidobacterium probiotics are also playing a crucial role. By highlighting the positive effects on gut health, these campaigns are attracting a larger customer base. As a result, the global bifidobacterium probiotic market is experiencing significant growth, driven by an informed and health-conscious consumer population.

For instance, on October 10, 2023, A Guangdong-based company, known for its expertise in producing popping candy as a staple food item, innovated its product line by incorporating functional ingredients to enhance nutritional value. The company has introduced a new range of candy infused with vitamin C and probiotics, specifically Bifidobacterium in the competitive market.

Traditionally recognized for its popping candy offerings, the company is leveraging its manufacturing techniques to create a novel candy experience enriched with health-promoting ingredients. By incorporating vitamin C and Bifidobacterium probiotics into the candy formulation, the company aims to provide consumers with a convenient and enjoyable way to boost their immune system and support digestive health.

Growing Preference for Natural and Organic Products

The growing preference for natural and organic products is a major factor driving the global bifidobacterium probiotic market. As consumers increasingly seek healthier and more sustainable options, they are turning to natural and organic probiotics to enhance their gut health. This trend is particularly strong among health-conscious individuals who prefer products free from synthetic additives and preservatives.

In response to this demand, manufacturers in the market are focusing on developing bifidobacterium probiotics that align with natural and organic standards. This shift is not only attracting a broader customer base but also encouraging innovation and product diversification within the market. Consequently, the preference for natural and organic products is significantly contributing to the expansion and growth of the global bifidobacterium probiotic market.

For instance, on April 28, 2022, China's dairy powerhouse, Yili, launched its latest product launch strategies, focusing on the introduction of innovative offerings to meet evolving consumer preferences. Among these strategies is the debut of a solid beverage enriched with probiotics and GABA as its primary ingredients. While Yili has established a strong presence in the dairy market, particularly with probiotic-infused products like yogurt, cheese, and ice cream, this new venture into solid beverages marks a strategic expansion of its product portfolio.

Stringent Regulatory Frameworks

Stringent regulatory frameworks are a significant restraint on the global bifidobacterium probiotic market. Regulatory bodies across different regions impose strict guidelines on the approval, labeling, and marketing of probiotic products to ensure safety and efficacy. These regulations often require extensive clinical trials and scientific evidence to substantiate health claims, which can be costly and time-consuming for manufacturers.

As a result, smaller companies face barriers to entry, and even established players in the market might experience delays in product launches and additional compliance costs. This regulatory burden can limit the speed at which new bifidobacterium probiotic products are brought to market and can also reduce the variety of products available to consumers. Stringent regulatory frameworks act as a significant constraint, impacting the growth and expansion of the global bifidobacterium probiotic market.

For instance, on December 27, 2023, The regulatory agency recently received a concerning adverse event report concerning a preterm infant who received treatment with the probiotic Evivo with MCT Oil (Infinant Health) as part of in-hospital care to prevent necrotizing enterocolitis. Tragically, following the administration of Evivo, the patient developed sepsis, attributed to the bacterium Bifidobacterium longum present in Evivo, and subsequently succumbed. This incident is among several reported cases where preterm infants experienced adverse events after receiving probiotics marketed as preventive measures against the disease.

Segment Analysis

The global bifidobacterium probiotic market is segmented based on type, form, application, end-user, and region.

Growing Innovations and Consumer Preference for Bifidobacterium longum

Consumers are increasingly seeking out probiotic products containing specific strains like Bifidobacterium longum due to their perceived health benefits and efficacy. This consumer preference drives demand for products containing this strain, contributing to its dominant position in the market. Bifidobacterium longum is commonly used in a variety of probiotic products. Its versatility and proven efficacy make it an attractive option for manufacturers looking to develop probiotic formulations to meet diverse consumer needs.

Bifidobacterium longum is one of the most extensively studied probiotic strains, with numerous clinical studies supporting its efficacy in promoting gut health and overall well-being. This robust scientific evidence enhances consumer confidence in the effectiveness of products containing Bifidobacterium longum, driving market demand. Companies often highlight the inclusion of Bifidobacterium longum in their products as a key selling point, leveraging its well-established reputation and positive consumer perception to drive sales and capture market share.

Geographical Penetration

Strong Tradition of Fermented Foods and Investments in Asia-Pacific

The Asia-Pacific region has a significant portion of the world's population, including densely populated countries like China and India. Many countries in the Asia-Pacific region have a long tradition of consuming fermented foods like yogurt, kimchi, and miso, which naturally contain probiotics. This cultural familiarity with probiotic-rich foods contributes to the growing acceptance and demand for bifidobacterium probiotics in the region.

Governments, academic institutions, and private companies in the Asia-Pacific region are investing heavily in research and development to explore the health benefits of probiotics and develop innovative products. This focus on innovation and product development is driving market growth and strengthening the region's position in the global bifidobacterium probiotic market.

COVID-19 Impact Analysis

The COVID-19 pandemic had a notable impact on the global bifidobacterium probiotic market. During the pandemic, there was a heightened focus on health and wellness, leading to increased consumer interest in products that support immune function and overall health, including bifidobacterium probiotics. This surge in demand positively influenced the market, as more individuals sought probiotics to boost their immunity and maintain gut health during a time of increased health awareness.

However, the market also faced challenges due to COVID-19. Supply chain disruptions and logistical issues caused delays in the production and distribution of probiotic products. Additionally, economic uncertainties led to cautious consumer spending, affecting the market's growth rate. Despite these challenges, the overall impact of COVID-19 has been a renewed emphasis on preventive health measures, which is likely to sustain the market's growth in the long term as consumers continue to prioritize their health post-pandemic.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has indirect effects on the global bifidobacterium probiotic market due to potential disruptions in the supply chain and geopolitical instability. Ukraine is a significant producer of grains, including wheat, which is a key ingredient in animal feed. Bifidobacterium probiotics are commonly used in animal feed to promote gut health and improve overall livestock health.

Disruptions in the Ukrainian grain market could lead to fluctuations in feed prices, affecting the livestock industry worldwide. This, in turn, may impact the demand for bifidobacterium probiotics, as farmers adjust their purchasing decisions based on feed costs. Geopolitical tensions and economic sanctions imposed on Russia and Ukraine could disrupt trade routes and distribution channels for bifidobacterium probiotic products.

By Type

Bifidobacterium animalis
Bifidobacterium longum
Bifidobacterium bifidum
Others

By Form

Dry
Liquid

By Application

Food & Beverages
Dietary Supplements
Pharmaceuticals
Animal Feed
Others

By End-User

Infants
Adults
Children
Animals

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

On January 30, 2023, Nissin Foods Group, announced the launch of Foods with Function Claims (FFCs) featuring lactic acid bacteria for the first time. This innovative move reflects the company's commitment to staying at the forefront of evolving consumer preferences and trends, particularly in the realm of gut health and the gut-brain axis.
On March 1, 2021, Bayer expanded its portfolio beyond gastrointestinal relief to address overall gut health with the introduction of two new probiotic products. Developed in collaboration with China's Jiangnan University, these probiotics are specifically formulated to target common gastrointestinal issues, including constipation and diarrhea.
On June 16, 2020, Yakult Japan introduced its inaugural shelf-stable probiotic supplement, marking a significant expansion in its product offerings. Packed into convenient sachets, this supplement contains two exclusive probiotic strains: the renowned lactic acid bacteria, Lactobacillus casei strain Shirota, and the beneficial bifidobacteria, Bifidobacterium breve strain Yakult.

Competitive Landscape

The major players in the global bifidobacterium probiotic market include DuPont, Goerlich Pharma GmbH, Mitushi Bio Pharma, and Chr. Hansen Holding A/S, Probi AB, Lallemand Inc., Novozymes A/S, Danone Corp, Nestle S.A., Yakult Honsha Co., Ltd.

Why Purchase the Report?

To visualize the global bifidobacterium probiotic market segmentation based on type, form, application, end-user, and region and understand critical commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous global streptococcus probiotic market-level data points with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of critical products of all the major players.

The global bifidobacterium probiotic market report would provide approximately 70 tables, 65 figures, and 213 users.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Form
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Consumer Awareness About Gut Health
  - 4.1.1.2. Growing Preference for Natural and Organic Products
- 4.1.2. Restraints
  - 4.1.2.1. Stringent Regulatory Frameworks
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Bifidobacterium animalis*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bifidobacterium longum
7.4. Bifidobacterium bifidum
7.5. Others

8. By Form

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2. Market Attractiveness Index, By Form
8.2. Dry*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Liquid

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Food & Beverages*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Dietary Supplements
9.4. Pharmaceuticals
9.5. Animal Feed
9.6. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Infants*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Adults
10.4. Children
10.5. Animals

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Russia
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. DuPont*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Goerlich Pharma GmbH
13.3. Mitushi Bio Pharma
13.4. Chr. Hansen Holding A/S
13.5. Probi AB
13.6. Lallemand Inc.
13.7. Novozymes A/S
13.8. Danone Corp
13.9. Nestle S.A.
13.10. Yakult Honsha Co., Ltd.

LIST NOT EXHAUSTIVE